Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma

Table 3

Diagnostic results for autoantibodies against Ezrin in ESCC.

	Sensitivity	Specificity	PPV	NPV	PLR	NLR
ESCC versus NC	27.5%	95.9%	91.1%	46.5%	6.74	0.76
Early-stage ESCC versus NC	27.8%	95.9%	55.4%	87.9%	6.78	0.75
Advanced ESCC versus NC	27.5%	95.9%	90.0%	49.7%	6.71	0.76

ESCC: esophageal squamous cell carcinoma; NC: normal controls; NLR: negative likelihood ratio; NPV: negative predictive value; PLR: positive likelihood ratio; PPV: positive predictive value.